Efficacy and Safety of LCZ696A in Patients With Essential Hypertension

NCT00549770 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

1334

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension

Interventions

DRUG: LCZ696
DRUG: Valsartan
DRUG: AHU377
DRUG: Placebo

Sponsor

Novartis Pharmaceuticals